DUBLIN--(BUSINESS WIRE)--The "Drug Eluting Stents (DES) (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.
This Medical Devices sector report provides comprehensive information about the Drug Eluting Stents (DES) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Report Scope:
- Extensive coverage of the Drug Eluting Stents (DES) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Drug Eluting Stents (DES) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Drug Eluting Stents (DES) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
-
In-depth analysis of the product's current stage of development, territory and estimated launch date
Key Topics Covered:
Drug Eluting Stents (DES) Overview
Products under Development
- Drug Eluting Stents (DES) - Pipeline Products by Stage of Development
- Drug Eluting Stents (DES) - Pipeline Products by Territory
- Drug Eluting Stents (DES) - Pipeline Products by Regulatory Path
- Drug Eluting Stents (DES) - Pipeline Products by Estimated Approval Date
- Drug Eluting Stents (DES) - Ongoing Clinical Trials
Drug Eluting Stents (DES) - Pipeline Products under Development by Companies
- Drug Eluting Stents (DES) Companies - Pipeline Products by Stage of Development
- Drug Eluting Stents (DES) - Pipeline Products by Stage of Development
Drug Eluting Stents (DES) Companies and Product Overview
Drug Eluting Stents (DES)- Recent Developments
Companies Mentioned
- Abbott Vascular Inc
- Adcomp Technologies Inc.
- Advanced Bifurcation Systems Inc
- Aeon Bioscience
- AlviMedica Medical Technologies Inc
- B. Braun Melsungen AG
- Biosensors International Group Ltd
- Biotronik AG
- Biotronik SE & Co KG
- Boston Scientific Corp
- Cardionovum GmbH
- Cardiorev Pte Ltd (Inactive)
- Columbia University
- Concept Medical Inc
- Cordis Corp
- DISA Vascular (Pty) Ltd
- Elixir Medical Corp
- Envision Scientific Pvt Ltd
- I.B.S. S.p.A.
- InspireMD Inc
- JW Medical Systems Ltd
- Kaneka Corp
- Liaoning Biomedical Materials R&D Center Co Ltd
- MangoGen Pharma Inc
- Medinol Ltd
- Medlogics Device Corp (Inactive)
- Medtronic Plc
- MicroPort Scientific Corp
- MIV Therapeutics Inc
- NuVascular Technologies Inc
- Relisys Medical Devices Ltd
- REVA Medical Inc
- Sahajanand Medical Technologies Pvt Ltd
- Shanghai Bio-heart Biological Technology Co Ltd
- Sino Medical Sciences Technology Inc
- Stentys SA
- Svelte Medical Systems Inc
- Terumo Corp
- Terumo Interventional Systems
- TissueGen Inc
- University of Strathclyde
- VasoTech Inc.
For more information about this report visit https://www.researchandmarkets.com/r/5r9ojt
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
